Margenza
| Margenza | |
|---|---|
| Term | Margenza |
| Short definition | Margenza - (pronounced) (mar-GEN-zuh) A medicine used with other medicines to treat adults with HER2-positive breast cancer that has spread to other parts of the body. It is used in patients who have already received at least two anti-HER2 treatments, including at least one anti-metastatic treatment. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Margenza - (pronounced) (mar-GEN-zuh) A medicine used with other medicines to treat adults with HER2-positive breast cancer that has spread to other parts of the body. It is used in patients who have already received at least two anti-HER2 treatments, including at least one anti-metastatic treatment. It is also being studied in the treatment of other types of cancer. Margenza attaches to a protein called HER2, which is found on some cancer cells. This can help the immune system kill cancer cells. Margenza is a type of monoclonal antibody. Also called margetuximab
External links
- Medical encyclopedia article on Margenza
- Wikipedia's article - Margenza
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski